A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Trial ID or NCT#
NCT05201781
Status
RECRUITING
Purpose
The purpose of this study is to collect long-term follow-up data on delayed adverse events after administration of ciltacabtagene autoleucel (cilta-cel), and to characterize and understand the long-term safety profile of cilta-cel.
Official Title
Long-term Follow-up Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes
Exclusion Criteria:
Investigator(s)
Surbhi Sidana, MD
Blood and marrow transplant specialist,
Hematologist-Oncologist
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Contact us to find out if this trial is right for you.
Contact
Kelly Chyan
650-625-8130
View on